Ungual hyalohyphomycosis caused by Fusarium proliferatum successfully treated with fosravuconazole
Abstract
Actually, it is not uncommon for it to be detected from superficial cutaneous specimens. Considering the thermosensitive nature of C. boppii, local hyperthermia is a reasonable treatment choice because it does not have systemic side-effects. As far as we know, our case is the first to apply local hyperthermia therapy to a C. boppii infection. We also administrated terbinafine instead of itraconazole to avoid a drug interaction with dabigatran. Our case suggests that local hyperthermia, along with systemic terbinafine, is a choice of treatment for phaeohyphomycosis caused by C. boppii.
Read the paper
Related studies
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- Challenges in Chagas Disease Drug Development
- T Cell Specificity: A Great Challenge in Chagas Disease
- Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
- Rapid Molecular Detection of Terbinafine-resistant Dermatophytes
- Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.